Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12615000009516
Ethics application status
Approved
Date submitted
12/11/2014
Date registered
8/01/2015
Date last updated
22/08/2016
Type of registration
Retrospectively registered
Titles & IDs
Public title
Mechanisms of an education intervention to remediate cognitive dysfunction associated with cancer and its treatment
Query!
Scientific title
Randomised controlled trial comparing the Responding to Cognitive Concerns (ReCog) cognitive-behavioural intervention to waitlist for subjective and objective cognitive function in cancer survivors
Query!
Secondary ID [1]
285648
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1164-0136
Query!
Trial acronym
ReCog RCT
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cancer-related cognitive dysfunction
293492
0
Query!
Condition category
Condition code
Cancer
293769
293769
0
0
Query!
Any cancer
Query!
Mental Health
294095
294095
0
0
Query!
Other mental health disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
"ReCog" is a four-week manualised intervention based on principles of cognitive behavioural therapy and cognitive rehabilitation. It comprises 4 two-hour sessions involving education, skills training and skills practice on topics such as memory and attention, and between-session homework. The intervention is delivered in weekly group sessions of 3-10 participants with 2 facilitators. Homework takes approximately 30-60 minutes per week. Treatment adherence is monitored via session attendance and homework completion
Query!
Intervention code [1]
290589
0
Rehabilitation
Query!
Comparator / control treatment
1. Waitlist group. These participants are offered the intervention after all assessments are completed (4.5 months after the initial assessment). Waitlist participants are able to access standard medical and health treatments, with no specific restrictions other than not participating in the ReCog intervention until after assessments are completed. 2. Healthy volunteers with similar age and education to cancer survivors participate as a further comparison group; they participate in assessments only and do not receive any treatment or training
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
293566
0
Subjective cognitive function, as assessed by the Functional Assessment of Cancer Therapy Cognitive Function 3 (FACT-Cog-3) and the Brief Assessment of Prospective Memory
Query!
Assessment method [1]
293566
0
Query!
Timepoint [1]
293566
0
Baseline, post-intervention (6 weeks after baseline) and follow-up (3 months after intervention completion)
Query!
Primary outcome [2]
293567
0
Objective cognitive function, as assessed by the Repeatable Battery for Assessment of Neuropsychological Status (RBANS) and the Trailmaking Test
Query!
Assessment method [2]
293567
0
Query!
Timepoint [2]
293567
0
Baseline, Post-intervention (6 weeks after baseline), and Follow-up (3 months after intervention)
Query!
Secondary outcome [1]
311378
0
Distress, as assessed by the Kessler Psychological Distress scale (K10)
Query!
Assessment method [1]
311378
0
Query!
Timepoint [1]
311378
0
Baseline, post-intervention (6 weeks after baseline) and follow-up (3 months after intervention completion)
Query!
Secondary outcome [2]
312081
0
Quality of life, as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire version 3 (EORTC-QLQ-C30)
Query!
Assessment method [2]
312081
0
Query!
Timepoint [2]
312081
0
Baseline, post-intervention (6 weeks after baseline) and follow-up (3 months after intervention completion)
Query!
Secondary outcome [3]
312084
0
Illness perceptions, as assessed by the Brief Illness Perceptions Questionnaire
Query!
Assessment method [3]
312084
0
Query!
Timepoint [3]
312084
0
Baseline, post-intervention (6 weeks after baseline) and follow-up (3 months after intervention completion)
Query!
Secondary outcome [4]
312086
0
Cognitive Self-Efficacy, as assessed by the Cognitive Self-Efficacy Scale
Query!
Assessment method [4]
312086
0
Query!
Timepoint [4]
312086
0
Baseline, post-intervention (6 weeks after baseline) and follow-up (3 months after intervention completion)
Query!
Secondary outcome [5]
312088
0
Benefit finding, as assessed by the Benefit Finding Scale
Query!
Assessment method [5]
312088
0
Query!
Timepoint [5]
312088
0
Baseline, post-intervention (6 weeks after baseline) and follow-up (3 months after intervention completion)
Query!
Eligibility
Key inclusion criteria
18 years or more; experienced adult-onset cancer (excluding cancer known to have affected the central nervous system); completed all major treatments for cancer (such as surgery, chemotherapy, and radiotherapy) at least 6 months prior to data collection (but ongoing hormone treatments were acceptable, e.g. oestrogen modifiers or androgen-suppressing medications); subjective cognitive impairment as shown by a score of <100 on the EORTC-QLQ-C30 cognitive function subscale. Healthy volunteers were required to be 18 years or over and have never been diagnosed with cancer.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Cancer known to involve the central nervous system (primary or secondary tumours). Previous treatment with cranial radiotherapy or intrathecal chemotherapy.
Query!
Study design
Purpose of the study
Educational / counselling / training
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes prepared by a researcher who is unconnected to the research project
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table from a statistics book
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Other
Query!
Other design features
Random allocation of cancer survivors to either immediate Intervention or Waitlist (delayed access to intervention). There was an additional Parallel group of healthy volunteers who had never experienced cancer.
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
A sample size of a minimum 20 participants per group was planned based on previous data showing effect sizes in the approximate range Cohen's d=0.5 to d=1.0. This would provide power of more than 80% at alpha level = .05, for detecting a Group x Time interaction. Analysis plan: Group x Time repeated measures ANOVAs.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/03/2012
Query!
Actual
3/04/2012
Query!
Date of last participant enrolment
Anticipated
3/09/2012
Query!
Actual
24/09/2012
Query!
Date of last data collection
Anticipated
Query!
Actual
7/03/2013
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
29
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Funding & Sponsors
Funding source category [1]
290233
0
University
Query!
Name [1]
290233
0
Griffith University
Query!
Address [1]
290233
0
Gold Coast Campus, Griffith University
Southport Qld 4222
Query!
Country [1]
290233
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Griffith University
Query!
Address
Gold Coast Campus, Griffith University
Southport Qld 4222
Query!
Country
Australia
Query!
Secondary sponsor category [1]
288941
0
None
Query!
Name [1]
288941
0
Query!
Address [1]
288941
0
Query!
Country [1]
288941
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
291937
0
Griffith University Human Research Ethics Committee
Query!
Ethics committee address [1]
291937
0
Griffith University Gold Coast campus Southport Qld 4222
Query!
Ethics committee country [1]
291937
0
Australia
Query!
Date submitted for ethics approval [1]
291937
0
14/02/2012
Query!
Approval date [1]
291937
0
09/03/2012
Query!
Ethics approval number [1]
291937
0
PSY/16/12/HREC
Query!
Summary
Brief summary
This study builds on and extends a previous project that tested a group intervention for cancer survivors who have experienced problems with cognitive functions such as attention and memory. The study uses a more rigorous research design (random allocation to treatment or waitlist) and also tests potential reasons that the treatment may be effective. It was hypothesised that participants in the treatment group would show bigger improvements in objective cognitive function, subjective cognitive function and other self-report measures than participants on a waitlist or healthy control participants. It was also predicted that better cognitive function would be associated with higher self-efficacy and more favourable illness perceptions
Query!
Trial website
Query!
Trial related presentations / publications
Borwick, S. (2013). Psychological mechanisms for improving cognitive function in cancer survivors: A randomised controlled trial. Doctor of Psychology (Clinical) dissertation, School of Applied Psychology, Griffith University, Gold Coast, Australia. King, S., & Green, H. J. (2015). Psychological intervention for improving cognitive function in cancer survivors: A literature review and randomized controlled trial. Frontiers in Oncology, 5. doi:10.3389/fonc.2015.00072
Query!
Public notes
Query!
Contacts
Principal investigator
Name
52714
0
Dr Summer King
Query!
Address
52714
0
C/- School of Applied Psychology
Gold Coast Campus, Griffith University
Parklands Drive, Southport Qld 4222
Query!
Country
52714
0
Australia
Query!
Phone
52714
0
+61,(0)7,56789086
Query!
Fax
52714
0
Query!
Email
52714
0
[email protected]
Query!
Contact person for public queries
Name
52715
0
Heather Green
Query!
Address
52715
0
School of Applied Psychology
Gold Coast Campus, Griffith University
Parklands Drive, Southport Qld 4222
Query!
Country
52715
0
Australia
Query!
Phone
52715
0
+61,(0)7,56789086
Query!
Fax
52715
0
Query!
Email
52715
0
[email protected]
Query!
Contact person for scientific queries
Name
52716
0
Heather Green
Query!
Address
52716
0
School of Applied Psychology
Gold Coast Campus, Griffith University
Parklands Drive, Southport Qld 4222
Query!
Country
52716
0
Australia
Query!
Phone
52716
0
+61,(0)7,56789086
Query!
Fax
52716
0
Query!
Email
52716
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF